Bright Minds

63.29
+1.88
+3.06%
DRUG
 64.95 61.70 11.21万股总市值 4.49亿
 59.85 1.58% 695.20万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
Bright Minds(DRUG)
09-05 18:05  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0002060755-25-000036  Act: 34  Size: 17 KB 网页链接
用户头像
Bright Minds(DRUG)
09-03 18:15  
$Bright Minds(DRUG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002807  Act: 33  Size: 1 KB 网页链接
用户头像
Bright Minds(DRUG)
08-26 18:05  
$Bright Minds(DRUG)$ F-3 Registration statement by foreign private issuers Accession Number: 0001062993-25-014903  Act: 33  Size: 821 KB 网页链接
用户头像
Bright Minds(DRUG)
08-15 18:15  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001062993-25-014464  Act: 34  Size: 787 KB 网页链接
用户头像
Bright Minds(DRUG)
08-14 23:05  
$Bright Minds(DRUG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000208  Act: 34  Size: 10 KB 网页链接
用户头像
Bright Minds(DRUG)
08-14 02:05  
$Bright Minds(DRUG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001214659-25-011955  Act: 34  Size: 9 KB 网页链接
用户头像
Bright Minds(DRUG)
08-11 18:05  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001062993-25-014005  Act: 34  Size: 765 KB 网页链接
用户头像
Bright Minds(DRUG)
05-29 03:45  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001183740-25-000037  Act: 34  Size: 11 KB 网页链接
用户头像
Bright Minds(DRUG)
05-21 18:05  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0002060755-25-000016  Act: 34  Size: 23 KB 网页链接
用户头像
Bright Minds(DRUG)
05-16 04:55  
$Bright Minds(DRUG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001415889-25-013183  Act: 34  Size: 18 KB 网页链接
用户头像
Bright Minds(DRUG)
05-16 04:35  
$Bright Minds(DRUG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950170-25-072739  Act: 34  Size: 10 KB 网页链接
用户头像
Bright Minds(DRUG)
05-14 18:05  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0002060755-25-000012  Act: 34  Size: 23 KB 网页链接
用户头像
Bright Minds(DRUG)
04-29 18:06  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001183740-25-000033  Act: 34  Size: 19 KB 网页链接
用户头像
Bright Minds(DRUG)
04-09 03:25  
$Bright Minds(DRUG)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001214659-25-005583  Act: 34  Size: 9 KB 网页链接
用户头像
Bright Minds(DRUG)
04-08 04:15  
$Bright Minds(DRUG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001274173-25-000106  Act: 34  Size: 10 KB 网页链接
用户头像
Bright Minds(DRUG)
03-05 19:06  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001183740-25-000029  Act: 34  Size: 29 KB 网页链接
用户头像
Bright Minds(DRUG)
02-25 01:15  
$Bright Minds(DRUG)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001183740-25-000026  Act: 34  Size: 10 KB 网页链接
用户头像
Bright Minds(DRUG)
02-18 19:05  
$Bright Minds(DRUG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-000478  Act: 33  Size: 1 KB 网页链接
用户头像
Bright Minds(DRUG)
02-15 05:55  
$Bright Minds(DRUG)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001062993-25-002569  Act: 33  Size: 206 KB 网页链接
用户头像
Bright Minds(DRUG)
02-15 05:15  
$Bright Minds(DRUG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001493152-25-006845  Act: 34  Size: 9 KB 网页链接